Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A. Kocher technique as default approach to aortic root enlargement.

JTCVS techniques·2026

Same author

Organ transplantation in Fontan patients-beware of false promises.

JHLT open·2026

Same author

Simultaneous transcatheter edge-to-edge repair (TEER) for severe mitral and tricuspid regurgitation is feasible, safe, and associated with good clinical outcome.

PloS one·2026

Same author

Letter to the Editor: Esophageal varices in Fontan patients-Circulatory or hepatic failure?

Hepatology (Baltimore, Md.)·2025

Same author

Gender-based outcomes following surgical aortic valve replacement: a multicentre propensity score matching analysis†.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2025

Same author

TEVAR versus open aortic arch replacement in ex vivo perfused human thoracic aortas.

Acta biomaterialia·2024

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Stem cells and cardiac regeneration.

Alfred A Kocher¹, Bernhard Schlechta, Aneta Gasparovicova

¹Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria. alfred.kocher@i-med.ac.at

Transplant International : Official Journal of the European Society for Organ Transplantation

|June 9, 2007

Summary

Stem cell therapy shows promise for heart failure (HF) patients, offering a potential new treatment for myocardial regeneration. This review examines current clinical trials and future directions for this innovative cardiac repair strategy.

More Related Videos

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Intramyocardial Cell Delivery: Observations in Murine Hearts

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Related Experiment Videos

Last Updated: Jul 14, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Intramyocardial Cell Delivery: Observations in Murine Hearts

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Area of Science:

Regenerative Medicine
Cardiovascular Research
Stem Cell Biology

Background:

Heart failure (HF) is a leading cause of death globally, with significant public health implications.
Existing treatments for HF have limitations, driving the search for novel therapeutic approaches.
Stem cell therapy has shown promise in preclinical models for cardiac repair.

Purpose of the Study:

To review the current evidence for stem cells in cardiac repair.
To provide an update on ongoing clinical trials of stem cell therapy for heart conditions.
To critically discuss the challenges and future prospects of stem cell-based myocardial regeneration.

Main Methods:

Literature review of preclinical studies and clinical trials.
Analysis of data from stem cell therapy applications in various cardiac diseases.
Critical evaluation of controversies and challenges in the field.

Main Results:

Stem cell therapy is feasible, safe, and potentially effective in human clinical studies for cardiac repair.
Cell-based myocardial regeneration is being explored for ischemic heart damage, cardiomyopathy, and as biological pacemakers.
Significant progress has been made, but challenges remain in optimizing efficacy and application.

Conclusions:

Stem cell therapy represents a promising novel therapeutic concept for heart failure and other cardiac conditions.
Further research and clinical trials are needed to overcome challenges and fully realize the potential of stem cell-based cardiac regeneration.
This approach holds potential for improving long-term outcomes for millions of heart failure patients worldwide.